Pipeline — registered trials by phase
Short-Term Clinical Comparison of Two Silicone Hydrogel Daily Disposable Contact Lenses
— · Visual Acuity · Completed · est. 2017-10-22
Nutritive Effects of Prebiotics on Early Postnatal Behavioral Measures of Tolerance
— · Behavioral Measures of Tolerance · Completed · est. 2016-03
Clinical Evaluation of Fitting Investigational Contact Lenses
— · Visual Acuity · Completed · est. 2017-03-31
Repeat Insult Patch Test APPENDIX I to HRL Standard Protocol #100
— · Allergic Sensitization · Completed · est. 2017-12-22
Controlling Myopia Progression With Soft Contact Lenses
— · Myopia · Completed · est. 2010-02-01
Evaluation of Daytime Corneal Swelling During Wear of Galyfilcon A Lenses
— · Myopia · Completed · est. 2011-12-01
Daily Disposable Performance of 1•DAY ACUVUE® TruEye™ and 1•DAY ACUVUE® MOIST® With LACREON® TECHNOLOGY
— · Myopia, Hyperopia · Completed · est. 2013-10
A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)
— · Arthritis, Psoriatic · Recruiting · est. 2027-06-05
Quantitative Study of New Limbal Ring Prototypes
— · Cosmetic Effect · Completed · est. 2014-06-01
Post Market Safety Study and Effectiveness With Evolence in Subjects With Skin Color Types IV-VI
— · Non Therapeutic Body Modification · Completed · est. 2009-11-30
Safety Study for an All-in-One Body and Personal Lubricant
— · Lubricating Agents · Completed · est. 2010-06
Investigational Multi-purpose Contact Lens Care Solution.
— · Contact Lens Wear · Completed · est. 2010-05
Evaluation of ACUVUE OASYS® 1-Day for Astigmatism Lenses Produced on a New Manufacturing Line
— · Visual Acuity · Completed · est. 2021-04-13
Clinical Evaluation of Approved and Investigational Contact Lenses
— · Visual Disorder · Completed · est. 2016-03
Health Economics Evaluation of Catheter Ablation Versus Drug Therapy in Atrial Fibrillation (AF) in China
— · Atrial Fibrillation · Completed · est. 2013-11-23
Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens
— · Refractive Ametropia · Completed · est. 2012-02
Dispensing Evaluation of a Galyfilcon A Prototype Lens and a Marketed Contact Lens
— · Myopia · Completed · est. 2010-07-01
Non-dispensing Study to Check Prescription Equivalence of Two Daily Disposable Toric Contact Lens Types
— · Astigmatism · Completed · est. 2010-02-01
A Comparison of Two Daily Disposable Soft Contact Lenses
— · Visual Acuity · Completed · est. 2015-04
Early DHA Supplementation in Very Low Birth Weight Infants
— · Prematurity · Completed · est. 2018-07-09
A Study to Evaluate and Compare the Efficacy of Two Facial Creams on Moderately to Severely Photodamaged Skin
— · Photodamaged Skin · Completed · est. 2025-05-01
A Study to Evaluate the Whitening Effect of Mineral Sunscreens in Multi-Cultural Skin Tones
— · Sunscreen · Completed · est. 2022-03-30
The Role of Spectral Filtering in a Spectrally Adjustable Ocular Photosensitivity Analyzer
— · Photosensitivity · Completed · est. 2022-05-16
Safety Evaluation of a New Preservative in a Lubricating Eye Drop
— · Dry Eye Syndromes · Completed · est. 2011-04
Evaluation of a Johnson & Johnson Vision Care Investigational Contact Lens Compared to a Marketed Monthly Replacement Contact Lens
— · Refractive Error · Completed · est. 2015-11
A Bioequivalence Study Between Two Brands of Medications to Treat Cough & Cold Symptoms
— · Bioequivalence, Healthy Volunteers · Completed · est. 2017-07-17
A Study of the Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and Vacaville
— · Schizophrenia · Completed
A Study to Assess the Pharmacokinetics and Pharmacodynamics of Canagliflozin (JNJ-28431754) in Healthy Indian Volunteers
— · Healthy · Completed · est. 2008-09
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
— · Neoplasms · Recruiting · est. 2028-11-08
A Study of Steady-state Carbamazepine on the Single-dose of Erdafitinib Tablets in Healthy Adult Participants
— · Healthy · Completed · est. 2022-06-14
A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or Separately
— · Human Volunteers, Migraine · Completed
A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine
— · Schizophrenia, Schizoaffective Disorder · Completed
A Pharmacokinetic Dose Proportionality Study of Canagliflozin in Healthy Volunteers
— · Healthy · Completed · est. 2011-08
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
— · Carcinoma, Non-small-Cell Lung · Active Not Recruiting · est. 2027-04-14
Study Evaluating and Comparing Single Dose and Multiple Dose Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese and Caucasian Adults.
— · Schizophrenia · Completed
A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies.
— · Protein Kinase Inhibitors, Antineoplastic Protocols, Clinical Trial, Phase 1 · Completed
An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast Cancer
— · Breast Neoplasms · Completed · est. 2011-08
Alternate Dosing of PROCRIT (Epoetin Alfa) in Patients With Cancer and Chemotherapy Induced Anemia
— · Anemia, Chemotherapy · Completed
Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas
— · Refractory Aggressive B-cell Lymphomas, Refractory B-Cell Non-Hodgkin Lymphoma, Aggressive B-cell NHL · Active Not Recruiting · est. 2024-11-23
Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients
— · Dry Eye · Completed · est. 2023-04-27
Naproxen Sodium/Acetaminophen Proof of Concept Dosing Study
— · Pain · Completed · est. 2019-11-07
An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes
— · Diabetes Mellitus, Type II, Diabetes Mellitus, Non Insulin Dependent · Completed · est. 2009-01
A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity
— · Obesity · Completed
A Study to Compare the Safety and Effectiveness of 2 Doses of Levofloxacin Given for Different Time Periods in Patients With Pneumonia
— · Pneumonia · Completed
A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Mercilon.
— · Contraception · Completed
A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine
— · Migraine, Common Migraine, Classic Migraine · Completed
Randomized, Double-Blind, Single-Dose, Efficacy and Safety Study of Test Acetaminophen Tablet in Postoperative Dental Pain
— · Post-operative Dental Pain · Completed · est. 2018-04-04
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
— · Pain · Completed · est. 2024-05-25
A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.
— · Bipolar Disorder · Completed
A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin
— · Obesity, Diabetes Mellitus, Type 2, Diabetes Mellitus, Adult-Onset · Completed
A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.
— · Contraception, Female Contraception · Completed
A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
— · Affective Psychosis, Bipolar, Bipolar Disorder, Mania · Completed
A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain
— · Osteoarthritis, Hip, Osteoarthritis, Knee, Lower Back Pain · Completed · est. 2008-07
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Johnson & Johnson is lead sponsor; 61 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- N-PX2026-08-11N-PX
- 13F-HR2026-08-0613F-HR
- 8-K2026-08-04Current report (material event)
- 8-K2026-07-29Current report (material event)
- 8-K2026-07-28Current report (material event)
- 10-Q2026-07-23Quarterly report
- 8-K2026-07-15Current report (material event)
- 11-K2026-06-2511-K
- 11-K2026-06-2511-K
- SD2026-05-27SD
- 13F-HR2026-05-1313F-HR
- SCHEDULE 13G2026-05-01SCHEDULE 13G
- 8-K2026-04-28Current report (material event)
- 10-Q2026-04-22Quarterly report
- 8-K2026-04-14Current report (material event)
- SCHEDULE 13G/A2026-04-13SCHEDULE 13G/A
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- 13F-HR/A2026-03-1813F-HR/A
- 13F-HR/A2026-03-1813F-HR/A
- ARS2026-03-11Annual report to holders
- DEFA14A2026-03-11DEFA14A
- DEF 14A2026-03-11Proxy statement
- 13F-HR2026-02-1313F-HR
- S-3ASR2026-02-11S-3ASR
- 10-K2026-02-11Annual report
- SCHEDULE 13G/A2026-02-05SCHEDULE 13G/A
- 8-K2026-01-21Current report (material event)
- SCHEDULE 13G/A2026-01-12SCHEDULE 13G/A
- 13F-HR2025-11-1313F-HR
- SCHEDULE 13G/A2025-10-22SCHEDULE 13G/A
- 10-Q2025-10-22Quarterly report
- 8-K2025-10-14Current report (material event)
- 8-K2025-09-09Current report (material event)
- N-PX2025-08-26N-PX
- 10-Q2025-07-24Quarterly report
- 13F-HR2025-07-2213F-HR
- 8-K2025-07-16Current report (material event)
- 11-K2025-06-2411-K
- 11-K2025-06-2411-K
- 8-K2025-06-10Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.